A 48-year-old woman presents to you for bilateral hearing loss, aural fullness, vertigo, nausea/vomiting, and tinnitus of two months’ duration.
![](https://www.enttoday.org/wp-content/uploads/springboard/image/2008_01_05.gif)
A 48-year-old woman presents to you for bilateral hearing loss, aural fullness, vertigo, nausea/vomiting, and tinnitus of two months’ duration.
An expert panel containing three former American Academy of Otolaryngic Allergy presidents recently provided a look at the future of allergic rhinitis, as well as a refresher on how best to treat it.
Pharmaceutical company representatives (PCRs) are as ubiquitous in otolaryngologists’ offices as seasonal allergies and ear infections.
Standards proposed by the United States Pharmacopeia (USP) for the compounding of sterile medication could be applied to vial mixing in the office.
A new Food and Drug Administration (FDA) advisory warns that the combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs) may result in life-threatening serotonin syndrome, which occurs when the body has too much serotonin.
Elderly patients have multiple reasons for losing their balance. Muscles are weaker, spines start to twist, bones may become brittle.
Recurrent respiratory papillomatosis (RRP) begins with a pretty small virus, relatively speaking, but it can lead to some pretty big problems for both the patient and the treating physician.
Otolaryngologists agree with their fellow physicians who prescribe drugs-pharmaceutical companies have no business buying or using information on how and when they prescribe particular drugs, nor do they want to be confronted by pharmaceutical company representatives in their office about why they do or don’t prescribe that company’s products.
Two studies look at trends in the cost and length of time spent developing new pharmaceuticals
Although most respiratory papillomatosis starts in childhood, some patients develop symptoms in adulthood.